Thomas Bartrum - Privia Health Executive Counsel
| PRVA Stock | USD 21.54 0.46 2.18% |
Executive
Thomas Bartrum is Executive Counsel of Privia Health Group
| Age | 56 |
| Address | 950 North Glebe Road, Arlington, VA, United States, 22203 |
| Phone | 571 366 8850 |
| Web | https://www.priviahealth.com |
Latest Insider Transactions
Thomas Bartrum Latest Insider Activity
Tracking and analyzing the buying and selling activities of Thomas Bartrum against Privia Health stock is an integral part of due diligence when investing in Privia Health. Thomas Bartrum insider activity provides valuable insight into whether Privia Health is net buyers or sellers over its current business cycle. Note, Privia Health insiders must abide by specific rules, including filing SEC forms every time they buy or sell Privia Health'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Thomas Bartrum over a week ago Disposition of 10634 shares by Thomas Bartrum of Privia Health at 26.3 subject to Rule 16b-3 |
Privia Health Management Efficiency
The current year's Return On Tangible Assets is expected to grow to 0.03. The current year's Return On Capital Employed is expected to grow to 0.04. At present, Privia Health's Net Tangible Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to about 54.4 M, whereas Total Current Assets are forecasted to decline to about 391.3 M. Privia Health's management efficiency ratios could be used to measure how well Privia Health manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Jonathan JD | Evolent Health | 56 | |
| Kevin JD | HealthStream | 54 | |
| Christophe Louvion | National Research Corp | 51 | |
| Linda Stacy | National Research Corp | N/A | |
| Kamesh Tumsi | HealthEquity | N/A | |
| Jennifer Presnell | Simulations Plus | N/A | |
| Benjamin Stilwill | Streamline Health Solutions | 35 | |
| Shawn OConnor | Simulations Plus | 64 | |
| Sheila MBA | Certara | N/A | |
| Jason Hahn | National Research Corp | 52 | |
| Brad Bennion | HealthEquity | N/A | |
| John III | Certara | 51 | |
| Daniel Corcoran | Certara | N/A | |
| Ron DiSantis | Certara | N/A | |
| Craig Hazenfield | Definitive Healthcare Corp | N/A | |
| Rona Anhalt | Certara | 59 | |
| Matt Ruderman | Definitive Healthcare Corp | N/A | |
| Richard Putnam | HealthEquity | N/A | |
| Jessica White | Evolent Health | N/A | |
| Richard CPA | Definitive Healthcare Corp | 55 | |
| Scott Fenstermacher | HealthStream | 55 | |
Management Performance
| Return On Equity | 0.0223 | ||||
| Return On Asset | 0.0077 |
Privia Health Group Leadership Team
Elected by the shareholders, the Privia Health's board of directors comprises two types of representatives: Privia Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Privia. The board's role is to monitor Privia Health's management team and ensure that shareholders' interests are well served. Privia Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Privia Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| MD FACOG, President Texas | ||
| Dana CPA, Senior Officer | ||
| Chris Voigt, Executive Officer | ||
| Jim MD, CEO Tennessee | ||
| Thomas Bartrum, Executive Counsel | ||
| Robert Borchert, Senior Communications | ||
| Jay Stevens, Senior Officer | ||
| Parth Mehrotra, CEO Director | ||
| Jenny Harding, Senior Operations | ||
| Edward Esq, General President | ||
| Matthew Morris, CEO Director | ||
| Eric Beyer, Executive Groups | ||
| Sarath Degala, Chief Officer |
Privia Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Privia Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0223 | ||||
| Return On Asset | 0.0077 | ||||
| Profit Margin | 0.01 % | ||||
| Operating Margin | 0.01 % | ||||
| Current Valuation | 2.11 B | ||||
| Shares Outstanding | 120 M | ||||
| Shares Owned By Insiders | 10.49 % | ||||
| Shares Owned By Institutions | 89.51 % | ||||
| Number Of Shares Shorted | 5.62 M | ||||
| Price To Book | 4.11 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Privia Health Group offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Privia Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Privia Health Group Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Privia Health Group Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Privia Health Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Privia Health. If investors know Privia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Privia Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.38) | Earnings Share 0.11 | Revenue Per Share 14.435 | Quarterly Revenue Growth 0.049 | Return On Assets 0.0077 |
The market value of Privia Health Group is measured differently than its book value, which is the value of Privia that is recorded on the company's balance sheet. Investors also form their own opinion of Privia Health's value that differs from its market value or its book value, called intrinsic value, which is Privia Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Privia Health's market value can be influenced by many factors that don't directly affect Privia Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Privia Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Privia Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Privia Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.